First, we used two selective antibodies against human ChAT and performed dot-blot analysis on pooled AD CSF and plasma samples (Fig. 1a, Blots I & II), and pooled brain homogenates (BH) from controls and AD patients (blots in Fig. 1b). This evidence concerns the gene CHAT and Alzheimer disease.